| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Andrade Robert | CHIEF FINANCIAL OFFICER | C/O FENNEC PHARMACEUTICALS, INC., PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK | /s/ Robert Andrade | 01 Jul 2025 | 0001468308 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FENC | Common shares | Award | $0 | +2,431 | +1.5% | $0.000000 | 163,382 | 30 Jun 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024. |